Cleavable Alpha-helical Presequences
Cleavable Alpha-helical Presequences - Related Videos
12:24
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
0 Views •
Cited by 9 •
2014
We present a combination of Cryo-electron microscopy, lipid nanotechnology, and structure analysis applied to resolve the membrane-bound structure of two highly homologous FVIII forms: human and porcine. The methodology developed in our laboratory to helically organize the two functional recombinant FVIII forms on negatively charged lipid nanotubes (LNT) is described.
09:22
Self-assembling Morphologies Obtained from Helical Polycarbodiimide Copolymers and Their Triazole Derivatives
0 Views •
2017
Here, we present a protocol to prepare and visualize secondary structures (e.g., fibers, toroidal architectures, and nano-spheres) derived from helical polycarbodiimides. The morphology characterized by both atomic force microscopy (AFM) and scanning electron microscopy (SEM) was shown to depend on molecular structure, concentration, and the solvent of choice.
12:38
Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction
0 Views •
Cited by 8 •
2011
This article describes a method to obtain a three-dimensional (3D) structure of helically assembled molecules using cryo-electron microscopy. In this protocol, we use HIV-1 capsid assemblies to illustrate the detailed 3D reconstruction procedure for achieving a density map by the iterative helical real-space reconstruction method.
01:30
Detection of Phosphorylated Alpha-Synuclein Using Western Blotting
0 Views •
2025
Add a loading buffer containing a detergent, a reducing agent, and a tracking dye.
03:25
Immunostaining of Neurons Treated with Alpha-Synuclein Aggregates
0 Views •
2025
This video demonstrates the immunostaining of neurons treated with alpha-synuclein (αS) aggregates. The neurons are first treated with αS aggregates. They are then fixed, permeabilized, and treated with a blocking solution. Primary antibodies are added, followed by a fluorescently labeled secondary antibodies and a nuclear stain. The sample is then mounted and observed under a microscope.
FAQs
The amphipathic alpha-helical arrangement separates chemical features across the signal: positively charged residues cluster on one face while the other face presents a different surface. This organization allows mitochondrial import receptors to recognize the presequence as a targeting signal rather than relying only on its short amino acid length. Recognition initiates delivery toward the membrane translocation machinery.
Once a presequence is recognized, mitochondrial import receptors guide the protein toward translocase complexes in the outer and inner membranes. These complexes provide the route across the mitochondrial boundary, linking initial signal recognition with delivery to the protein’s final mitochondrial location. This coordinated handoff explains how an N-terminal signal can control intracellular trafficking.
Cleavage converts the imported precursor into the mature protein. Specialized peptidases remove the presequence after the protein reaches the mitochondrial matrix or inner membrane, separating the targeting segment from the functional protein product. The processing step therefore marks successful delivery and helps distinguish the temporary trafficking signal from the protein’s mature form.
Targeting depends on the combination of an N-terminal position, an amphipathic alpha-helical shape, and a positively charged face. Considering these features together is important because the signal is not described simply as a linear sequence; its three-dimensional presentation enables receptor recognition and subsequent mitochondrial import. This provides a structural basis for analyzing targeting behavior.
They can serve as targeting elements when researchers design experiments to redirect a protein toward mitochondria. Examining whether the protein reaches the organelle, undergoes presequence removal, or appears in the matrix or inner membrane connects signal design with trafficking outcome. Such experiments help clarify mitochondrial protein targeting and test engineered localization strategies.
These signals offer a way to direct engineered or therapeutic proteins to a mitochondrial destination rather than leaving localization unspecified. Their use links sequence design with intracellular placement, while cleavage can yield a mature protein after import. The broader value is strategic: manipulating targeting may help place designed proteins where mitochondrial biology makes them relevant.